Product category:
Genomics
News Release from: GE Healthcare | Subject: Spa GPCR protocols
Edited by the Laboratorytalk Editorial
Team on 16 September 2004
Pre-validated protocols save time
Assay development time will be reduced with the introduction of a range of pre-developed protocols for G-protein-coupled receptors (GPCR) membranes
GE Healthcare, a combination of the former Amersham and GE Medical Systems, is to help further address bottlenecks in the drug discovery process with the introduction of a range of pre-developed protocols for G-protein-coupled receptors (GPCR) membranes These pre-validated protocols offer substantial time-savings of up to 15 days during the GPCR assay development stage
This article was originally published on Laboratorytalk on 18 Apr 2003 at 8.00am (UK)
Related stories
Tips to improve radiochemical safety
Contains reaction-sized aliquots of radionucleotide in a solution-free format, making experiments easier and safer to do
The new scintillation proximity assay (SPA) GPCR assays offer researchers working in high throughput screening environments pre-developed assay conditions for GPCR receptor-ligand binding studies.
"GE Healthcare is continually working to help cut development time throughout the drug discovery process," comments John Sutton, vice president product management, cell analysis and screening at GE Healthcare.
"This is the first time that Spa GPCR protocols have been available in this way.
"By providing ready-made optimum assay conditions for GPCR ligand binding studies, GE Healthcare is reducing assay development process time for researchers, therefore enabling them to focus on screening potential drug candidates".
These Spa GPCR assays broaden GE Healthcare's SPA range and comprise Spa beads and radioligands from GE Healthcare with GPCR receptor membranes from Euroscreen, as well as a pre-validated protocol describing the required procedure for the GPCR assay.
• GE Healthcare: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

